Exercise and acupressure pilot leaves symptom benefits uncertain during cancer immunotherapy
A feasibility study found partial completion of exercise goals, while unclear symptom comparisons and inconsistent pain reporting limit conclusions about benefit.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The combined home exercise and acupressure program was tested mainly to see whether it could be delivered and followed during cancer immunotherapy. Participants completed some, but not all, exercise goals. The abstract reports improvements in fatigue and social functioning, yet unclear comparisons and inconsistent pain reporting leave its symptom benefits uncertain.
The abstract calls the pain result significant despite P=0.30, and does not clarify whether symptom changes were compared with another group. Small pilot groups further limit interpretation.
What researchers found
Exercise goals achieved
Proportion of exercise goals achieved in TEHEplus during the 12-week program; no between-group comparison of this measure is reported.
Testing delivery
Researchers first sought patient feedback on the digital tools and study procedures, then randomly assigned patients to the program variants or usual care. They assessed participation, adherence and outcomes from baseline to program completion.
What the results establish
Fatigue and social functioning were reported as improved in the combined group. The abstract does not provide effect sizes or clear comparisons against usual care, so the size and clinical relevance of any benefit remain uncertain.
The original publication
Combined technology-enhanced home exercise and acupressure (TEHEplus) program on symptoms among cancer patients receiving immunotherapy: a feasibility study.
Lukkahatai N, Benjasirisan C, Shen A et al.
BMC Cancer · 2025
- PubMed ID
- 41034793
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.